Nifty

:

22795.90

Sensex

:

75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Login

Nifty
Sensex

:
:

22795.90
75311.06

-117.25 (-0.51%)
-424.90 (-0.56%)

Chandra Bhagat Pharma Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 542934 | NSE: Not Listed

Watchlist

NSE BSE

65

21-Feb-2025

Open
High
Low
Previous Close

67
67
63
67.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

11000
727010
143.25
58.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

49.04
32.05
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

60.51
N/A
1.77

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-

P:BV (Average)

8 Years
5 Years
3 Years

-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales - 221.37 119.67 94.08 70.70 93.98 106.28 97.06 89.79 79.84 61.13 Net Sales Growth - 84.98% 27.20% 33.07% -24.77% -11.57% 9.50% 8.10% 12.46% 30.61% Cost Of Goods Sold - 208.04 106.58 81.36 59.74 85.80 92.36 82.39 73.60 62.97 44.72 Gross Profit - 13.34 13.09 12.72 10.95 8.18 13.91 14.67 16.18 16.87 16.41 GP Margin - 6.03% 10.94% 13.52% 15.49% 8.70% 13.09% 15.11% 18.02% 21.13% 26.84% Total Expenditure - 228.57 116.49 91.33 67.01 90.86 101.69 92.47 85.42 75.56 58.14 Power & Fuel Cost - 0.09 0.07 0.07 0.05 0.08 0.09 0.09 0.09 0.10 0.00 % Of Sales - 0.04% 0.06% 0.07% 0.07% 0.09% 0.08% 0.09% 0.10% 0.13% 0% Employee Cost - 2.18 1.32 1.52 1.85 2.25 4.53 5.02 5.64 7.31 7.05 % Of Sales - 0.98% 1.10% 1.62% 2.62% 2.39% 4.26% 5.17% 6.28% 9.16% 11.53% Manufacturing Exp. - 3.85 0.63 0.27 0.19 0.06 0.22 0.47 0.72 0.04 0.00 % Of Sales - 1.74% 0.53% 0.29% 0.27% 0.06% 0.21% 0.48% 0.80% 0.05% 0% General & Admin Exp. - 5.76 3.17 2.11 1.78 1.33 1.92 1.85 2.57 4.42 6.37 % Of Sales - 2.60% 2.65% 2.24% 2.52% 1.42% 1.81% 1.91% 2.86% 5.54% 10.42% Selling & Distn. Exp. - 8.57 3.84 3.32 3.02 1.17 2.30 2.33 1.33 0.69 0.00 % Of Sales - 3.87% 3.21% 3.53% 4.27% 1.24% 2.16% 2.40% 1.48% 0.86% 0% Miscellaneous Exp. - 0.09 0.88 2.69 0.38 0.16 0.26 0.32 1.47 0.01 0.00 % Of Sales - 0.04% 0.74% 2.86% 0.54% 0.17% 0.24% 0.33% 1.64% 0.01% 0% EBITDA - -7.20 3.18 2.75 3.69 3.12 4.59 4.59 4.37 4.28 2.99 EBITDA Margin - -3.25% 2.66% 2.92% 5.22% 3.32% 4.32% 4.73% 4.87% 5.36% 4.89% Other Income - 11.33 0.29 1.62 0.48 0.44 0.44 0.67 0.49 0.39 0.31 Interest - 1.39 2.20 3.24 3.76 3.11 4.09 3.67 3.81 3.71 2.35 Depreciation - 0.49 0.11 0.04 0.12 0.03 0.05 0.06 0.14 0.24 0.26 PBT - 2.26 1.16 1.10 0.28 0.42 0.89 1.53 0.91 0.72 0.69 Tax - 0.73 0.26 0.30 0.09 0.11 0.20 0.50 0.25 0.37 0.27 Tax Rate - 32.30% 22.41% 27.27% 32.14% 26.19% 22.47% 32.68% 27.47% 51.39% 39.13% PAT - 1.53 0.91 0.80 0.19 0.31 0.69 1.03 0.66 0.35 0.43 PAT before Minority Interest - 1.53 0.91 0.80 0.19 0.31 0.69 1.03 0.66 0.35 0.43 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 0.69% 0.76% 0.85% 0.27% 0.33% 0.65% 1.06% 0.74% 0.44% 0.70% PAT Growth - 68.13% 13.75% 321.05% -38.71% -55.07% -33.01% 56.06% 88.57% -18.60% EPS - 2.04 1.21 1.07 0.25 0.41 0.92 1.37 0.88 0.47 0.57

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 29.01 27.48 26.68 25.88 25.69 14.45 8.44 7.41 6.75 6.40 Share Capital 7.55 7.55 7.55 7.55 7.55 0.67 0.42 0.42 0.42 0.42 Total Reserves 21.46 19.93 19.13 18.33 18.14 13.78 8.03 6.99 6.33 5.98 Non-Current Liabilities 1.72 6.16 7.74 13.03 14.98 15.90 20.96 11.28 0.03 -0.09 Secured Loans 0.58 0.63 1.74 3.19 1.04 3.65 3.49 0.00 0.00 0.00 Unsecured Loans 0.83 3.30 3.68 6.26 9.84 7.81 8.25 4.22 0.00 0.00 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 71.06 26.95 38.05 32.87 34.07 52.50 28.63 37.18 37.71 35.89 Trade Payables 13.23 3.10 2.67 12.85 12.49 29.70 15.48 16.27 5.66 5.29 Other Current Liabilities 43.17 9.81 20.72 4.08 4.87 6.26 2.62 4.32 0.31 3.10 Short Term Borrowings 14.06 13.74 14.39 15.63 16.62 16.32 10.01 16.28 29.58 27.50 Short Term Provisions 0.60 0.29 0.27 0.30 0.10 0.22 0.52 0.31 2.16 0.00 Total Liabilities 101.79 60.59 72.47 71.78 74.74 82.85 58.03 55.87 44.49 42.20 Net Block 2.52 0.73 0.47 0.42 0.44 0.46 0.51 0.55 0.69 0.87 Gross Block 3.78 1.50 1.13 1.26 1.24 1.24 1.23 0.70 0.69 0.87 Accumulated Depreciation 1.25 0.77 0.66 0.84 0.81 0.78 0.72 0.14 0.00 0.00 Non Current Assets 2.52 0.73 0.47 0.42 0.44 0.46 0.51 0.59 0.73 0.87 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.04 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 97.92 58.09 70.73 70.01 72.87 81.29 57.05 55.27 43.75 41.33 Current Investments 0.13 0.11 0.22 0.00 0.75 4.03 1.05 4.64 0.00 0.00 Inventories 8.68 29.08 34.16 35.14 43.90 43.91 32.64 26.75 21.19 21.65 Sundry Debtors 39.45 8.19 15.00 15.42 14.03 26.30 17.86 19.66 14.47 11.89 Cash & Bank 4.96 6.44 5.68 2.82 0.05 0.48 0.55 0.58 4.68 5.05 Other Current Assets 44.70 0.05 0.03 0.02 14.13 6.56 4.95 3.65 3.42 2.74 Short Term Loans & Adv. 44.44 14.23 15.63 16.61 13.94 6.51 4.95 3.65 3.42 2.74 Net Current Assets 26.86 31.14 32.67 37.14 38.80 28.79 28.42 18.09 6.05 5.44 Total Assets 101.78 60.59 72.46 71.78 74.75 82.84 58.03 55.86 44.48 42.20

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 6.18 5.26 12.40 8.33 -7.41 4.05 -6.18 -9.03 0.00 0.00 PBT 2.26 1.16 1.10 0.28 0.42 0.89 1.53 0.91 0.00 0.00 Adjustment 1.87 2.29 3.03 3.46 2.69 3.82 3.13 3.17 0.00 0.00 Changes in Working Capital 2.50 2.14 8.38 4.68 -10.53 -0.18 -10.55 -12.86 0.00 0.00 Cash after chg. in Working capital 6.63 5.60 12.50 8.42 -7.41 4.53 -5.89 -8.77 0.00 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.46 -0.23 -0.11 -0.10 0.00 -0.47 -0.28 -0.25 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 -0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.85 -0.06 0.09 0.12 0.05 -0.40 -0.36 0.30 0.00 0.00 Net Fixed Assets -2.28 -0.37 0.13 -0.02 0.00 -0.01 -0.53 -0.01 0.18 0.15 Net Investments -0.02 0.11 -0.22 0.75 3.28 -2.98 3.59 -4.64 0.00 0.00 Others 0.45 0.20 0.18 -0.61 -3.23 2.59 -3.42 4.95 -0.18 -0.15 Cash from Financing Activity -5.80 -4.45 -9.62 -6.42 6.94 -3.73 6.51 7.97 0.00 0.00 Net Cash Inflow / Outflow -1.48 0.76 2.86 2.02 -0.43 -0.08 -0.02 -0.75 0.00 0.00 Opening Cash & Equivalents 6.44 5.68 2.82 0.80 0.48 0.55 0.58 1.33 0.00 0.00 Closing Cash & Equivalent 4.96 6.44 5.68 2.82 0.05 0.48 0.55 0.58 0.00 0.00

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 36.67 34.08 33.68 32.51 32.15 199.21 190.69 177.27 161.47 153.01 ROA 1.89% 1.36% 1.10% 0.26% 0.40% 0.98% 1.82% 1.85% 0.82% 1.16% ROE 5.73% 3.54% 3.19% 0.78% 1.67% 6.46% 13.44% 11.96% 5.38% 6.89% ROCE 8.22% 7.37% 8.83% 7.63% 7.16% 13.40% 17.58% 22.28% 12.62% 10.40% Fixed Asset Turnover 83.97 91.18 78.60 56.37 75.67 85.91 100.61 74.53 102.19 64.62 Receivable days 39.27 35.37 59.02 76.02 78.31 75.83 70.57 49.58 60.23 61.07 Inventory Days 31.12 96.43 134.43 204.05 170.53 131.45 111.66 63.87 97.93 110.65 Payable days 14.33 9.89 34.83 77.41 85.90 74.26 60.02 33.98 27.86 32.42 Cash Conversion Cycle 56.06 121.91 158.62 202.66 162.94 133.02 122.20 79.47 130.30 139.30 Total Debt/Equity 0.59 0.74 0.83 1.10 1.23 2.34 2.73 2.98 4.38 4.30 Interest Cover 2.63 1.53 1.34 1.07 1.14 1.22 1.42 1.24 1.19 1.30

Top Investors:

alacrity securities limited

team anamika algo limited

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback